Who Paid My Doc
WaveCrest Vs. Watchman Transseptal LAA Closure to Reduce AF Mediated Stroke 2
Research payments
$728,794
Through program year 2024, $728,794 in research payments was reported against WaveCrest Vs. Watchman Transseptal LAA Closure to Reduce AF Mediated Stroke 2, across 487 payments, paid by Medical Device Business Services, Inc..
- Paid by
- Medical Device Business Services, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $143,036 | 45 |
| 2023 | Research | $170,870 | 134 |
| 2022 | Research | $151,263 | 116 |
| 2021 | Research | $263,626 | 192 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Chinmay Patel Lancaster, PA Named on 51 payments
- Jose Osorio Birmingham, AL Named on 45 payments
- Stanislav Weiner Longview, TX Named on 36 payments
- Nabil Dib Gilbert, AZ Named on 34 payments
- James Stone Tupelo, MS Named on 31 payments
- Gery Tomassoni Lexington, KY Named on 19 payments
- James Deville Plano, TX Named on 15 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.